Skip to content

H.R. 9559 · 119th Congress (2025–2027)

IBOGAINE Act

To accelerate the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States, and for other purposes.

CRS summary not yet available.

Referred to committee

Latest actionReferred to Health

This bill’s path

This is H.R. 9559’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Morgan Luttrell (R-TX-8)
Cosponsors
5 cosponsors

3 original · 2 later

  1. Rep. Jack Bergman (R-MI-1)· Original · Jun 30, 2026
  2. Rep. J. Luis Correa (D-CA-46)· Original · Jun 30, 2026
  3. Rep. Michael T. McCaul (R-TX-10)· Original · Jun 30, 2026
  4. Rep. Mike Collins (R-GA-10)· Later · Aug 31, 2026
  5. Rep. Sarah Elfreth (D-MD-3)· Later · Sep 15, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Jun 30, 2026 – Jul 17, 2026
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources

Committees

  1. HouseEnergy and CommerceReferred Jun 30, 2026
  2. HouseJudiciaryReferred Jun 30, 2026
  3. HouseVeterans' AffairsReferred Jun 30, 2026
  4. HouseHealthReferred Jul 17, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. IBOGAINE Act

    Display title, Short title · Introduced in House

  2. Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy Act

    Short title · Introduced in House

  3. To accelerate the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States, and for other purposes.

    Official title · Introduced in House